Filtros : "Instituto Butantan (IB)" "Emirados Árabes Unidos" "IQ" Removido: "1984" Limpar

Filtros



Limitar por data


  • Fonte: Current Medicinal Chemistry. Unidade: IQ

    Assuntos: SCHISTOSOMA MANSONI, PRODUTOS NATURAIS

    Acesso à fonteAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MORAES, J et al. In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Shistosoma mansoni schistosomula and adult worms. Current Medicinal Chemistry, v. 20, n. 2, p. 301-309, 2013Tradução . . Disponível em: http://www.sciencedirect.com/science/article/pii/S0731708512004876. Acesso em: 13 out. 2024.
    • APA

      Moraes, J., Keiser, J., Ingram, K., Nascimento, C., Yamaguchi, L. F., Bittencourt, C. R., et al. (2013). In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Shistosoma mansoni schistosomula and adult worms. Current Medicinal Chemistry, 20( 2), 301-309. doi:10.1016/j.jpba.2012.08.028
    • NLM

      Moraes J, Keiser J, Ingram K, Nascimento C, Yamaguchi LF, Bittencourt CR, Bemquerer MP, Leite JR, Kato MJ, Nakano E. In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Shistosoma mansoni schistosomula and adult worms [Internet]. Current Medicinal Chemistry. 2013 ; 20( 2): 301-309.[citado 2024 out. 13 ] Available from: http://www.sciencedirect.com/science/article/pii/S0731708512004876
    • Vancouver

      Moraes J, Keiser J, Ingram K, Nascimento C, Yamaguchi LF, Bittencourt CR, Bemquerer MP, Leite JR, Kato MJ, Nakano E. In vitro synergistic interaction between amide piplartine and antimicrobial peptide dermaseptin against Shistosoma mansoni schistosomula and adult worms [Internet]. Current Medicinal Chemistry. 2013 ; 20( 2): 301-309.[citado 2024 out. 13 ] Available from: http://www.sciencedirect.com/science/article/pii/S0731708512004876
  • Fonte: Recent Patents on CNS Drug Discovery. Unidade: IQ

    Assunto: DOENÇAS NEURODEGENERATIVAS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RESENDE, Rodrigo Ribeiro e ULRICH, Henning e FARIA, Marcella. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation. Recent Patents on CNS Drug Discovery, v. 2, n. 1, p. 37-46, 2007Tradução . . Disponível em: https://doi.org/10.2174/157488907779561736. Acesso em: 13 out. 2024.
    • APA

      Resende, R. R., Ulrich, H., & Faria, M. (2007). Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation. Recent Patents on CNS Drug Discovery, 2( 1), 37-46. doi:10.2174/157488907779561736
    • NLM

      Resende RR, Ulrich H, Faria M. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation [Internet]. Recent Patents on CNS Drug Discovery. 2007 ;2( 1): 37-46.[citado 2024 out. 13 ] Available from: https://doi.org/10.2174/157488907779561736
    • Vancouver

      Resende RR, Ulrich H, Faria M. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation [Internet]. Recent Patents on CNS Drug Discovery. 2007 ;2( 1): 37-46.[citado 2024 out. 13 ] Available from: https://doi.org/10.2174/157488907779561736

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024